
InDevR launches VaxArray Measles and Rubella Kit for improved vaccine antigen characterization
BOULDER -- InDevR, Inc. announced commercial availability of its VaxArray Measles and Rubella (MR) antigen quantification kit. Funded by the Bill and Melinda Gates Foundation with the goal of... Read More
Tuesday January 19, 2021 0 comments